Can you take Mounjaro (tirzepatide) while breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

It is not known if MOUNJARO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while using MOUNJARO.

Mounjaro and Breastfeeding: It is not known if Mounjaro (tirzepatide) passes into breast milk. Therefore, it is recommended to talk to your healthcare provider about the best way to feed your baby while using Mounjaro. 1

From the Research

It is not recommended to take Mounjaro (tirzepatide) while breastfeeding, as there is currently insufficient data on the safety of tirzepatide during lactation, and it is unknown whether the medication passes into breast milk or what effects it might have on a nursing infant 2, 3, 4, 5. The manufacturer advises against using Mounjaro during breastfeeding due to this lack of safety information.

Key Considerations

  • The primary concern is the potential risk to the infant, as the effects of tirzepatide on infant development and health are not well understood.
  • There is a lack of research on the safety of tirzepatide during breastfeeding, making it difficult for healthcare providers to assess potential risks.
  • Alternative medications, such as metformin or insulin, have better established safety profiles during lactation and may be considered as alternatives.

Recommendations

  • If you need medication to manage diabetes or weight while breastfeeding, consult with your healthcare provider about alternative options.
  • Your doctor can help weigh the potential risks and benefits based on your specific health situation.
  • Caution is advised when considering the use of newer medications like tirzepatide during breastfeeding, due to the lack of research on breastfeeding outcomes.

Additional Information

  • The studies provided do not specifically address the safety of tirzepatide during breastfeeding, but rather its efficacy and safety in treating type 2 diabetes and obesity 2, 3, 4, 5.
  • The manufacturer's advice against using Mounjaro during breastfeeding is based on the lack of safety information, and healthcare providers should exercise caution when considering its use in breastfeeding women.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.